HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Carbamylcholine

HCID 2551
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
462-58-8
Standard SMILES
C[N+](C)(C)CCOC(N)=O
InChIKey
VPJXQGSRWJZDOB-UHFFFAOYSA-O
Molecular formula
C6H15N2O2+
Average molar mass
147.2 g/mol
Monoisotopic mass
147.11335273

Overview

Carbamoylcholine, also known as carbachol, is a muscarinic agonist discovered in 1932. Carbamoylcholine was initially used as a treatment for migraines, induction of diuresis, and other parasympathetic effects. Carbamoylcholine was granted FDA approval on 28 September 1972.

Names & identifiers

Preferred name
Carbamylcholine
IUPAC
2-carbamoyloxyethyl(trimethyl)azanium
English name
N,N,N-Trimethyl-2-(carbamoyloxy)ethanaminium
Molecular formula
C6H15N2O2
Molecular weight
0

Names & synonyms

CarbamylcholineCarbamoylcholine462-58-8choline carbamate54Z8M50D6QEthanaminium, 2-((aminocarbonyl)oxy)-N,N,N-trimethyl-DTXSID0048397RefChem:54708DTXCID50283702-(trimethylazaniumyl)ethyl carbamate2-(carbamoyloxy)-N,N,N-trimethylethanaminium2-carbamoyloxyethyl(trimethyl)azanium
Show more names
N,N,N-Trimethyl-2-(carbamoyloxy)ethanaminium
2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium2-[(AMINOCARBONYL)OXY]-N,N,N-TRIMETHYLETHANAMINIUM(2-Carbamoyloxy-ethyl)-trimethyl-ammoniumCHEMBL14CARBAMYL-CHOLINE(carbachol)(2-Carbamoyloxy-ethyl)-trimethyl-ammoniumCholine, carbonate (ester)CCE

Database identifiers

CAS
462-58-8、51-83-2
PubChem CID
2551
DTXSID
DTXSID0048397
ChEMBL
CHEMBL965
UNII
54Z8M50D6Q
Nikkaji
J2.049D

Properties

Computed structural propertiesFilling in

XLogP
-0.4
Topological polar surface area
52.3 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
2
Rotatable bonds
4
Heavy atoms
10
Formal charge
1
Complexity
117

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LogP-3.78
Solubility9.48e-01 g/L
Human DrugsPharmaceuticals
Melting Point · 2 items

208-210

210 °C

Physical DescriptionSolid

Physicochemical properties

FDA UNII
54 Z8M50D6Q · 54Z8M50D6Q

Chemistry & industry

Pharmacology

Protein BindingData regarding protein binding of carbamoylcholine is not readily available.
Pharmacodynamics · 1 item

Carbamoylcholine is a parasympathomimetic that acts as an agonist of muscarinic and nicotinic receptors. It is more resistant to hydrolysis by acetylcholinesterase than other choline esters leading to a longer duration of action, with significant effects 24 hours after administration. Data regarding the therapeutic index of carbamoylcholine is not readily available. Patients should be counselled regarding the risk of administering the drug to patients with acute cardiac failure, bronchial asthma, peptic ulcer, hyperthyroidism, gastrointestinal spasm, urinary tract obstruction, or Parkinson's disease.

Mechanism of ActionCarbamoylcholine is a parasympathomimetic that acts as an agonist of muscarinic and nicotinic receptors. Intraocular administration leads to miosis and decreases intraocular pressure via increased aqueous humour outflow.
Biological Half-LifeData regarding the half life of carbamoylcholine is not readily available.
Metabolism/MetabolitesThe metabolism of carbamoylcholine has not been well described in the literature. It is metabolized to a small extent by acetylcholinesterase.
FDA Pharmacological Classification · 5 items

54Z8M50D6Q

CARBAMOYLCHOLINE

Mechanisms of Action [MoA] - Cholinergic Agonists

Established Pharmacologic Class [EPC] - Cholinergic Receptor Agonist

Carbamoylcholine is a Cholinergic Receptor Agonist. The mechanism of action of carbamoylcholine is as a Cholinergic Agonist.

MeSH Pharmacological Classification · 4 items

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes

Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here.

Drugs that bind to and activate cholinergic receptors.

A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS.

Absorption, Distribution and Excretion · 4 items

Choline esters in general are hydrophilic and therefore poorly absorbed through the gastrointestinal tract and are unlikely to cross the blood brain barrier. Data regarding the absorption of carbamoylcholine are not readily available.

Data regarding the route of elimination of carbamoylcholine is not readily available.

Data regarding the volume of distribution of carbamoylcholine is not readily available.

Data regarding the clearance of carbamoylcholine is not readily available.

Cellular LocationsMembrane

Uses & manufacturing

Use ClassificationPharmaceuticals